Chargement en cours...
Antiviral properties of two trimeric recombinant gp41 proteins
BACKGROUND: As it is the very first step of the HIV replication cycle, HIV entry represents an attractive target for the development of new antiviral drugs. In this context, fusion inhibitors are the third class of anti-HIV drugs to be used for treatment, in combination with nucleoside analogues and...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2006
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1435769/ https://ncbi.nlm.nih.gov/pubmed/16515685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-4690-3-16 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|